Mammalian Cell Banking Market

Global Market Study on Mammalian Cell Banking: Increasing Focus on Oncological Research Surging Market Growth

Mammalian Cell Banking Market is segmented by Cell, Transient Expression Platforms, Inducible Expression Platforms, Stable Expression Platforms, Cell Bank

  • July-2020
  • PMRREP31663
  • 251 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Introduction

Potentially, mammalian cell culture has helped oncology research the most, as cancer cells are more responsive to culture in vitro. Cell lines provide an indefinite source of biological material for experimental purposes.

Funding for cancer research from government authorities in Asia Pacific are increasing the scope for mammalian cell bank service providers. For instance, in 2019, Cancer Research U.K. and the Indian government’s Department of Biotechnology launched a US$ 12.7 Mn, 5-year initiative.

Rising burden of cancer cases is increasing the demand for preclinical studies. This is the key factor increasing the mammalian cell banking market size.

The National Cancer Institute (NCI) along with other institutes invest in major research initiatives to facilitate and support research on specific issues of importance to the cancer research enterprise.

These initiatives include Cancer Moonshot, The National Clinical Trials Network (NCTN), NCI Genomic Data Commons (GDC), the RAS Initiative, NCI Community Oncology Research Program (NCORP), etc. 

Financial support for cancer research by government and non-governmental organizations is growing, which will boost the growth of the mammalian cell banking market over the coming years.

Find Out More about the Report Coverage

Companies

  • Sartorius Stedim BioOutsource Limited.
  • Charles River Laboratories.
  • Eurofins DiscoverX Corporation
  • Merck KGaA
  • Lonza Group Ltd
  • VIRUSURE
  • Altogen Labs
  • Abzena Ltd
  • Northway Biotechpharma
  • Selexis SA

Mammalian Cell Banking Market Trends

Mammalian cells are regularly used in the biopharmaceutical industry for the production of recombinant therapeutic proteins. Moreover, mammalian cell lines are used as host cells for the production of biologics in the biopharmaceutical industry.

Improved post cryopreservation technology is used by cell banks to improve cell recovery. Additionally, cryopreserved cell lines are provided in multiple vials to prevent potential contamination and genetic variation by eliminating the multiple handling and revive processes of cell lines during the research process.

This will increase product adaption amongst researchers. It will also lead to successful cryopreservation of cell lines that play a key role in establishing viable biopharmaceutical production processes.

Moreover, cryopreservation is more significant than traditional protocols for cell preservation. This is a key factor anticipated to aid the growth of the mammalian cell banking market.

mammalian cell banking market

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Regional Outlook of Mammalian Cell Banking Market

North America and Europe currently hold more than 49% of the global mammalian cell banking market share. High prevalence of cancer and increasing cancer research are surging the demand for mammalian cell banking in North America.

However, the market East Asia and South Asia will experience significant growth over the forecast period, owing to factors such as increased burden of cancer, large population base, and tremendous use of cell lines for research projects. Increased R&D investments and government initiatives are expected to boost the demand for mammalian cell banking in these regions.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Impact of COVID-19 

The COVID-19 pandemic will have a positive impact on the progress of the mammalian cell banking market. Potential research is going on for COVID-19 vaccines. During clinical trials of COVID-19 vaccines, demand for cell lines has increased.

This will boost the growth of the mammalian cell banking market. This is benefiting the stock prices of biopharmaceutical industries, which will complement the growth of the mammalian cell banking market.

Explore Persistence Market Research’s expertise in promulgation of the business !

Analysts’ Viewpoint

An extensive analysis of the mammalian cell banking market has brought our analysts to a conclusion that, the market is growing at a significant pace. Currently, CHO cells is the target segment for major players, and hence, this segment dominates the global mammalian cell banking market in term of growth. Europe and North America collectively hold more than 50% revenue share, due to high adoption of mammalian cell banking in these regions. Emerging countries such as Brazil, China, and India are expected to offer lucrative opportunities for players in the mammalian cell banking market, owing to increasing awareness and initiatives by local governments for research & development on cancer.

Key Segments of Mammalian Cell Banking Market

PMR’s study on the mammalian cell banking market offers information divided into five important segments— cell, technology, cell bank , end user, and region. This report offers comprehensive data and information about important market dynamics and growth parameters associated with these categories.

Cell

  • CHO
  • BHK
  • NS0
  • YB2/0 & P2/0
  • HEK293 & Derivatives
  • HELA

Technology

  • Transient Expression Platforms
  • Inducible Expression Platforms
  • Stable Expression Platforms

Cell Bank

  • Master Cell Banks (MCBs)
  • Working Cell Banks (WCBs)
  • End of Production Cell Banks (EoPCBs)
  • Research & Development Cell Banks (R&D CBs)

End User

  • Academic & Research Laboratories
  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Key Questions Answered in PMR’s Mammalian Cell Banking Market Report

  • Which regions will continue to remain the most profitable regional markets for mammalian cell banking market players?
  • Which factors will induce a change in the demand for mammalian cell banking during the assessment period?
  • How will changing trends impact the mammalian cell banking market?
  • How can market players capture the low-hanging opportunities in the mammalian cell banking in developed regions?
  • What are the winning strategies of stakeholders in the mammalian cell banking market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the mammalian cell banking market?
  • What are the developmental trends in the mammalian cell banking sectors that will impact the market?
  • How can businesses in the mammalian cell banking market avail the growth opportunities in developed and emerging sectors?

Media Release

Recommendations

Oligonucleotide Synthesis Market

Global Oligonucleotide Synthesis Market is anticipated to reach a market size of over US$ 540 Mn by 2025 end, growing at a CAGR of 8.6%. More details inside.

Health Caregiving Market

Global health caregiving market was pegged at more than US $ 70 Bn in 2015 & is estimated to cross US $ 200 bn by the end of 2024, registering a CAGR of 12.6%.

Atherectomy and Thrombectomy Devices Market

The atherectomy and thrombectomy devices market is predicted to grow from US$ 3.5 billion in 2022 to US$ 6 billion in 2032. Previously, the market was thriving at a higher CAGR of 6.3% (2015-2021), resulting in a market size of US$ 3.3 billion in 2021..

Automated Liquid Handling Systems Market

Global Automated liquid handling workstation market is projected to surpass US$ 700 million in terms of value along with a healthy CAGR by the year 2026 end.

Our Clients

Our Clients